English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 6 June 2023, 20:51 HKT/SGT
Share:
    

Source: Inclusology
SaaS Inclusology Releases New 2.0 Platform and Proves to Help Companies Achieve DEI (Diversity, Equity, and Inclusion) Goals in Accelerated Timeline

PHOENIX, Arizona, June 6, 2023 - (ACN Newswire) - Inclusology, is a powerful all in one DEI management SaaS platform designed to help companies reduce bias in the workplace and increase employee retention. Last week, the platform released its new version after completing beta testing among 16 companies and thousands of employees across startups, nonprofits, Fortune 500 and 1000 companies etc.


"We are so proud to see Inclusology's work having a positive impact on DEI at a global level in every sized company," says CEO Dr. Cheryl Ingram. "We've tested our software in a number of different companies and we have a good idea of what companies need in order to solve issues related to DEI. Our solution is using demographic data to conduct DEI (diversity, equity, and inclusion) assessments to analyze, report, benchmark, provide e-learning and development opportunities, certifications, and recommend solutions for diversity, equity, and inclusion (DEI). We're different because we help you put DEI in your DNA and not as a separate initative or program."

The average results of the beta testing have included: increasing employee retention by up to 75%, and improving diverse employee recruitment by up to 25% in a one year time frame.

The company, which has been in beta the last 5 years, offers an all around DEI experience. The product provides the following features:
- A DEI questions banks for auditing/assessment
- Industry DEI benchmarking
- DEI training modules that allow for clients to earn certifications in a number of different areas
- Automated strategic planning
- Direct access to industry professionals

Our goal is to really build a platform that is inclusive of all identities and allows employees a safe and enjoyable work environment no matter their identities.

About Inclusology

Inclusology was founded in 2018 by Dr. Cheryl Ingram and launched the first alpha test in 2019. Since its origin, it has run assessments for companies such as Netflix, Parametrix, and others. The company was founded in Seattle and has since moved its HQ to Omaha, NE. Inclusology's mission is to make the workplace all inclusive and safe for everyone. The company currently has 5 full time employees with a combined experience of over 40 years in the industry. They have previously raised 1.2 million dollars through a pree-seed and seed round. They are currently raising a 2 million dollar bridge round to close their Pre-Series A.

If you'd like to learn more about or have a free demo please contact the company directly by filling out an info form HERE (www.inclusology.com/contact-and-support) or scheduling time for a demo HERE. For additional information you can contact the company at info@inclusology.com.

Topic: Press release summary
Source: Inclusology

Sectors: Enterprise IT
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
CITIC Telecom CPC Wins Two Awards, Celebrating 'Innovation Never Stops' for 25 Years, recognizing Cybersecurity & Innovation Excellence  
Feb 9, 2026 13:28 HKT/SGT
JCB Announces Collaboration with Resorts World Sentosa in Singapore  
Monday, February 9, 2026 1:00:00 PM
Anime Tokyo Station: "That Time I Got Reincarnated as a Slime" Special Exhibition, February 21 to May 24, 2026  
Monday, February 9, 2026 10:00:00 AM
playX Secures Industry-Leading Player Protection Through Landmark Insurance Partnership with Great American Insurance Group  
Feb 8, 2026 23:30 HKT/SGT
Mr Liu Xiaojun, on behalf of Fufeng Group, has fully completed the acquisition of Viva World Trade, Inc.  
Feb 7, 2026 05:45 HKT/SGT
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets  
Feb 6, 2026 17:45 HKT/SGT
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share  
Feb 6, 2026 17:01 HKT/SGT
COSMOPlat Introduces Full-Stack AI to Hong Kong for Trillion-Dollar Industrial Digitalization  
Feb 6, 2026 16:34 HKT/SGT
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis  
Feb 6, 2026 14:17 HKT/SGT
Spritzer Celebrates Continued Excellence with Dual Recognition at Putra Brand Awards 2025 and Superior Taste Award 2025  
Feb 6, 2026 13:13 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575